REV-ERB agonist raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-27 and is reviewed periodically as new material appears.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
Pyroglutamate aminopeptidase is a type of enzyme that cleaves the peptide bond linking the N-terminal end of a polypeptide forming a cyclical lactam to the next amino acid residue. This cyclic structure protects the polypeptide from degradation but renders the protein difficult to analyze in the laboratory. Pyroglutamate aminopeptidase may be used to cleave the cyclical lactam and will therefore leave the next amino acid with a free N-terminal.
=== Biochemical applications === In general, SEC is considered a low-resolution chromatography as it does not discern similar species very well, and is therefore often reserved for the final step of a purification. The technique can determine the quaternary structure of purified proteins that have slow exchange times, since it can be carried out under native solution conditions, preserving macromolecular interactions. SEC can also assay protein tertiary structure, as it measures the hydrodynamic volume (not molecular weight), allowing folded and unfolded versions of the same protein to be distinguished. For example, the apparent hydrodynamic radius of a typical protein domain might be 14 Å and 36 Å for the folded and unfolded forms, respectively. SEC allows the separation of these two forms, as the folded form elutes much later due to its smaller size.
A recipe from 1909 adds onions and tomato sauce, and serves it with crisp potato straws, which are considered the traditional side dish for beef Stroganoff in Russia. The version given in the 1938 Larousse Gastronomique includes beef strips, and onions, with either mustard or tomato paste optional. After the fall of the Russian monarchy in 1917, the recipe was popularly served in the hotels and restaurants of China before the start of World War II. The first English cookbook to include a recipe for beef Stroganoff is Ambrose Heath's Good Food (1932). The dish came to Hong Kong in the late 1950s. In 1960s United States, several manufacturers introduced dehydrated beef stroganoff mixes, which were mixed with cooked beef and sour cream. It was also available freeze-dried for campers.
=== 3D devices for glucose detection === Whitesides' group also developed a 3D paper-based microfluidic device for glucose detection that can produce calibration curves on-chip because of the improved fluid flow design. This 3D device consists of layers of paper patterned with microfluidic channels that are connected by layers of double-sided adhesive tape with holes. The holes in the tape permit flow between channels in alternating layers of paper, so this device allows for more complicated flow paths and enables the detection of multiple samples in a large number (up to ~1,000) of detection zones in the last layer of paper. More recently, 3D paper-based microfluidic devices assembled using origami were developed. Unlike Whitesides' design, these devices utilize a single layer of patterned paper that is then folded into multiple layers before sample solution is injected into the device. Subsequently, the device can be unfolded, and each layer of the device can be analyzed for the simultaneous detection of multiple analytes. This device is simpler and less expensive to fabricate than the aforementioned device using multiple layers of paper. Mixing between the channels in the different layers was not an issue in either device, so both devices were successful in quantifying glucose and BSA in multiple samples simultaneously.
Sources: en.wikipedia.org
== Preservation and diagenesis == Steroids are often preserved in petroleum as saturated and aromatic steroidal hydrocarbons that result from transformations occurring during diagenesis. After senescence of steroids from aquatic producers, they undergo rapid re-mineralization under aerobic conditions in the upper water column. A small percentage of the intact sterols produced in the euphotic zone endure diagenesis, where microbial mediated transformations effectively yield compounds that can then be related back to their parent sterols and are more stable in the geologic record. The preservation of sterols is often limited, but is enhanced by anaerobic conditions during their deposition and subsequent diagenesis, in particular, early sulfurization and reduction mediated by sulfur species. Intact dinosterol has been reported from sediments of the presumed late Jurassic age, possibly due to incomplete degradation of lipids in the water column under high productivity conditions in the presence of sulfate reducers. These transformations are controlled by microbial activity and low temperature physiochemical reactions. Thermodynamically driven abiotic physicochemical reactions further alter the steroids by causing complete aromatization, isomerization and cracking of the steroids. These more stable compounds co-exist with their precursor sterols and their intermediate diagenetic products can only occur in immature sediments when incomplete microbial degradation has occurred.
For services to Animal Health and voluntary service to Sport. Madeleine Clare Hinch, MBE. For services to Hockey. Elaine Hinchliffe-Dale (Elaine Dale). Director, Special Educational Needs and Disabilities Support, City College Norwich. For services to Further Education. Dr. Elizabeth Janine Hogben. Lately Secretary, Prime Minister's Council for Science and Technology, Government Office for Science. For services to Science in Government. Lady (Patricia Ann) Hopkins. For services to Architecture. Carol Wai Wing Hui. Lately Board Member, British Tourist Authority. For services to Tourism. Mahboob Hussain, JP. For services to the community in Buckinghamshire. Elizabeth Louise Hutton. Chief Executive Officer, Kicks Count. For services to Education and Prevention of Stillbirths. Alasdair Bruce Jackson. Chief Executive, Recycling Lives Charity. For services to the Rehabilitation of Offenders. Kerry Joanne Jackson. Chief Executive, St Gemma's Hospice. For services to Palliative and End of Life Care. Salim Hassanali Moledina Janmohamed. For charitable and voluntary services to Faith Communities. Peter Jefferies. Team Leader, Ministry of Defence. For services to Defence. Timothy Nigel Jenkins. Lately District Judge, Brentford County Court. For services to the Administration of Justice. Peter Sinclair Jensen. Lately Chair of Trustees, Home of Horseracing Trust and Chair, British Sporting Arts Trust. For Charitable Service. Dr. Christopher Paul Johnson. Forensic Pathologist, Home Office. For services to Criminal Justice. Christopher Jolly. Publisher, Jolly Phonics.
== Funding and infrastructure == Initial construction costs were covered by the ERDF and Czech state funds. Operational funding comes from competitive grants, including Czech Science Foundation (GACR) awards and Horizon Europe projects. The campus features a cogeneration plant and rainwater recycling systems.
Sources: en.wikipedia.org
Droplet-based microfluidics manipulate discrete volumes of fluids in immiscible phases with low Reynolds number (<< 2300) and laminar flow regimes. An early example for using droplet-based microfluidics was a flow-through chip reactor for miniaturized PCR. Interest in droplet-based microfluidics systems has been growing substantially in past decades. Microdroplets offer the feasibility of handling miniature volumes (μL to fL) of fluids conveniently, provide better mixing, encapsulation, sorting, sensing and are suitable for high throughput experiments. Two immiscible phases used for the droplet based systems are referred to as the continuous phase (medium in which droplets flow) and dispersed phase (the droplet phase), resulting in either water-in-oil (W/O) or oil-in-water (O/W) emulsion droplets.
=== Indoor air-quality measurements === Measurement of VOCs from the indoor air is done with sorption tubes e. g. Tenax (for VOCs and SVOCs) or DNPH-cartridges (for carbonyl-compounds) or air detector. The VOCs adsorb on these materials and are afterwards desorbed either thermally (Tenax) or by elution (DNPH) and then analyzed by GC–MS/FID or HPLC. Reference gas mixtures are required for quality control of these VOC measurements. Furthermore, VOC emitting products used indoors, e.g. building products and furniture, are investigated in emission test chambers under controlled climatic conditions. For quality control of these measurements round robin tests are carried out, therefore reproducibly emitting reference materials are ideally required. Other methods have used proprietary Silcosteel-coated canisters with constant flow inlets to collect samples over several days. These methods are not limited by the adsorbing properties of materials like Tenax.
A ketogenic amino acid is an amino acid that can be degraded directly into acetyl-CoA, which is the precursor of ketone bodies and myelin, particularly during early childhood, when the developing brain requires high rates of myelin synthesis. This is in contrast to the glucogenic amino acids, which are converted into glucose. Ketogenic amino acids are unable to be converted to glucose as both carbon atoms in the ketone body are ultimately degraded to carbon dioxide in the citric acid cycle. In humans, two amino acids – leucine and lysine – are exclusively ketogenic. Five more are amphibolic (both ketogenic and glucogenic): phenylalanine, isoleucine, threonine, tryptophan and tyrosine. The remaining thirteen are exclusively glucogenic.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.